Using botulinum toxin to treat diabetic foot pain.
Kaufman
Jacob L
JL
Karceski
Steven
S
D019274:Botulinum Toxins, Type A / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D003929:Diabetic Neuropathies / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D005528:Foot / Q000294:innervation / Q000503:physiopathology*; D006801:Humans; D006943:Hyperglycemia / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control; D009498:Neurotoxins / Q000494:pharmacology / Q000627:therapeutic use; D010147:Pain Measurement / Q000379:methods; D011984:Sensory Receptor Cells / Q000187:drug effects / Q000473:pathology; D016896:Treatment Outcome
D009498:Neurotoxins; D019274:Botulinum Toxins, Type A